Uterine Fibroids
|
0.300 |
Biomarker
|
group |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Uterine Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Pleural effusion disorder
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
INHBA, which encodes a member of the TGF-beta superfamily of proteins, has been identified to play a critical role in different types of cancer.
|
29950896 |
2018 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Relative INHBA gene expression was measured in surgical specimens of cancer tissue and adjacent normal mucosa by quantitative real-time, reverse-transcription polymerase chain reaction.
|
24778035 |
2014 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
In addition, knockdown of INHBA in cancer cells impaired cancer xenograft growth through reducing OC stromal fibroblast activation <i>in vivo.</i> Further results confirmed that Smad2 signaling pathway was involved in INHBA-induced stromal fibroblast activation, and inhibiting this pathway could effectively reverse activation of stromal fibroblasts.
|
31827640 |
2019 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
In some cancer cell lines, the gene encoding activin A (inhibin βA [INHBA]) is over-expressed and enhances cancer proliferation.
|
20926007 |
2010 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
In addition, knockdown of INHBA in cancer cells impaired cancer xenograft growth through reducing OC stromal fibroblast activation <i>in vivo.</i> Further results confirmed that Smad2 signaling pathway was involved in INHBA-induced stromal fibroblast activation, and inhibiting this pathway could effectively reverse activation of stromal fibroblasts.
|
31827640 |
2019 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
INHBA, which encodes a member of the TGF-beta superfamily of proteins, has been identified to play a critical role in different types of cancer.
|
29950896 |
2018 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
In some cancer cell lines, the gene encoding activin A (inhibin βA [INHBA]) is over-expressed and enhances cancer proliferation.
|
20926007 |
2010 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Relative INHBA gene expression was measured in surgical specimens of cancer tissue and adjacent normal mucosa by quantitative real-time, reverse-transcription polymerase chain reaction.
|
24778035 |
2014 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
In clinical samples, ANLN and INHBA showed a significantly higher expression in tumors than in normal tissues.
|
17982635 |
2007 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
In stage I AD patients, high levels of primary tumor INHBA transcripts were associated with worse prognosis.
|
19308293 |
2009 |
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
LHGDN |
Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
|
12088879 |
2002 |
Endometrial Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
|
12088879 |
2002 |
Metabolic Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The unique presence of serpin A3-7, coiled-coil domain containing 88A and inhibin/activin β A chain in HR-EXO, indicates potential biomarkers for cows at-risk for metabolic diseases.
|
31554846 |
2019 |
Pre-Eclampsia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Oxidative stress increases placental and endothelial cell activin A secretion.
|
17332518 |
2007 |
Pre-Eclampsia
|
0.310 |
AlteredExpression
|
phenotype |
LHGDN |
Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia.
|
14671202 |
2003 |
Abdomen distended
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abdominal mass
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ascites
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysmenorrhea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Menorrhagia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nausea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|